Stockreport

Acadia Receives A Rubber Stamp From FDA On Nuplazid Risk-Benefit Profile [Seeking Alpha]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF Summary The FDA issues a press release reaffirming that the risk-benefit profile for Nuplazid remains solid despite safety concerns. Nuplazied sales reached $57 [Read more]